Marc Umscheid - Net Worth and Insider Trading

Marc Umscheid Net Worth

The estimated net worth of Marc Umscheid is at least $57 dollars as of 2024-11-12. Marc Umscheid is the Chief Strategy/Mkt Officer of Sonoma Pharmaceuticals Inc and owns about 19 shares of Sonoma Pharmaceuticals Inc (SNOA) stock worth over $57. Details can be seen in Marc Umscheid's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marc Umscheid has not made any transactions after 2017-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Marc Umscheid

To

Marc Umscheid Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Marc Umscheid owns 1 companies in total, including Sonoma Pharmaceuticals Inc (SNOA) .

Click here to see the complete history of Marc Umscheid’s form 4 insider trades.

Insider Ownership Summary of Marc Umscheid

Ticker Comapny Transaction Date Type of Owner
SNOA Sonoma Pharmaceuticals Inc 2017-08-10 Chief Strategy/Mkt Officer

Marc Umscheid Latest Holdings Summary

Marc Umscheid currently owns a total of 1 stock. Marc Umscheid owns 19 shares of Sonoma Pharmaceuticals Inc (SNOA) as of August 10, 2017, with a value of $57.

Latest Holdings of Marc Umscheid

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SNOA Sonoma Pharmaceuticals Inc 2017-08-10 19 3.02 57

Holding Weightings of Marc Umscheid


Marc Umscheid Form 4 Trading Tracker

According to the SEC Form 4 filings, Marc Umscheid has made a total of 0 transactions in Sonoma Pharmaceuticals Inc (SNOA) over the past 5 years. The most-recent trade in Sonoma Pharmaceuticals Inc is the acquisition of 3 shares on August 10, 2017, which cost Marc Umscheid around $3,186.

Insider Trading History of Marc Umscheid

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Marc Umscheid Trading Performance

GuruFocus tracks the stock performance after each of Marc Umscheid's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Marc Umscheid is -4%. GuruFocus also compares Marc Umscheid's trading performance to market benchmark return within the same time period. The performance of stocks bought by Marc Umscheid within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Marc Umscheid's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Marc Umscheid

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.97 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.87 LIMIT LIMIT LIMIT LIMIT LIMIT

Marc Umscheid Ownership Network

Ownership Network List of Marc Umscheid

No Data

Ownership Network Relation of Marc Umscheid

Insider Network Chart

Marc Umscheid Owned Company Details

What does Sonoma Pharmaceuticals Inc do?

Who are the key executives at Sonoma Pharmaceuticals Inc?

Marc Umscheid is the Chief Strategy/Mkt Officer of Sonoma Pharmaceuticals Inc. Other key executives at Sonoma Pharmaceuticals Inc include Interim CFO Chad Norman White , Chief Financial Officer Jerome J Dvonch , and Chief Financial Officer Robert Grant Edwards .

Sonoma Pharmaceuticals Inc (SNOA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sonoma Pharmaceuticals Inc (SNOA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonoma Pharmaceuticals Inc (SNOA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sonoma Pharmaceuticals Inc (SNOA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sonoma Pharmaceuticals Inc Insider Transactions

No Available Data

Marc Umscheid Mailing Address

Above is the net worth, insider trading, and ownership report for Marc Umscheid. You might contact Marc Umscheid via mailing address: Oculus Innovative Sciences, Inc., 1129 N. Mcdowell Blvd., Petaluma Ca 94954.